DBCO-PEG4-Ahx-DM1 - HY-136260

Catalog #
HY-136260
2.376,00 €
DBCO-PEG4-Ahx-DM1 is a agent-linker conjugate composed of a potent microtubulin inhibitor DM1 and a linker DBCO-PEG4-Ahx to make antibody agent conjugate (ADC). Mertansine (DM1) is a microtubulin inhibitor and is an antibody-conjugatable maytansinoid that is developed to overcome systemic toxicity associated with maytansine and to enhance tumor-specific delivery. DBCO-PEG4-Ahx-DM1 is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Weitere Informationen
Datasheet URL http://file.medchemexpress.com/batch_PDF/HY-136260/DBCO-PEG4-Ahx-DM1-DataSheet-MedChemExpress.pdf
Quantity 1mg
Shipping Blue Ice
Application Cancer-programmed cell death
CAS 2479378-44-2
Storage -20°C, 3 years (Powder)
MWT 1297.92
Solubility 10 mM in DMSO
Clinical Information No Development Reported
Target Drug-Linker Conjugates for ADC
Applications
Application: Cancer-programmed cell death

Newsletter
abonnieren

15% Rabatt

erhalten